Esperion Therapeutics Inc (ESPR)
2.13
+0.04
(+1.91%)
USD |
NASDAQ |
Apr 24, 16:00
2.17
+0.04
(+1.88%)
After-Hours: 04:39
Esperion Therapeutics Revenue (TTM): 116.33M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 116.33M |
| September 30, 2023 | 102.90M |
| June 30, 2023 | 87.91M |
| March 31, 2023 | 80.97M |
| December 31, 2022 | 75.48M |
| September 30, 2022 | 72.06M |
| June 30, 2022 | 67.49M |
| March 31, 2022 | 89.30M |
| December 31, 2021 | 78.45M |
| Date | Value |
|---|---|
| September 30, 2021 | 72.68M |
| June 30, 2021 | 62.11M |
| March 31, 2021 | 233.68M |
| December 31, 2020 | 227.55M |
| September 30, 2020 | 218.89M |
| June 30, 2020 | 216.04M |
| March 31, 2020 | 4.785M |
| December 31, 2019 | 148.36M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
4.785M
Minimum
Mar 2020
233.68M
Maximum
Mar 2021
115.00M
Average
87.91M
Median
Jun 2023
Revenue (TTM) Benchmarks
| United Therapeutics Corp | 2.328B |
| Masimo Corp | 2.048B |
| Heron Therapeutics Inc | 127.04M |
| Aldeyra Therapeutics Inc | -- |
| Ocugen Inc | -- |